
Oxford Capital
Description
Oxford Capital is a prominent UK-based venture capital firm with offices in Oxford and London, specializing in early-stage and growth-stage technology companies. Established with a clear focus on disruptive innovation, the firm primarily targets high-growth sectors such as artificial intelligence, fintech, health tech, and enterprise software. Their investment philosophy centers on identifying ambitious founders and providing not just capital but also strategic guidance and operational support to help scale their ventures.
The firm employs a flexible investment approach, backing companies from seed through to Series A and beyond, often participating in follow-on rounds to support portfolio companies' continued expansion. Oxford Capital is particularly known for its expertise in managing Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) funds, which are crucial mechanisms for fostering early-stage investment in the UK. This allows them to support a diverse range of innovative startups across various technology verticals, contributing significantly to the UK's tech ecosystem.
Oxford Capital typically deploys initial cheques ranging from approximately $625,000 to $6.25 million, depending on the stage and specific needs of the company. However, they are prepared to make substantial follow-on investments as companies mature and require additional capital for growth. The firm has a strong track record, having helped their portfolio companies raise over £500 million (approximately $625 million) in total capital to date, underscoring their commitment to long-term value creation. Their strategic involvement and deep industry connections aim to accelerate the development and market penetration of their portfolio companies.
Investor Profile
Oxford Capital has backed more than 191 startups, with 5 new investments in the last 12 months alone. The firm has led 48 rounds, about 25% of its total and boasts 18 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, France.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Led 4 rounds in the past year.
- Typical check size: $625K – $6.3M.
Stage Focus
- Series Unknown (65%)
- Seed (13%)
- Series A (9%)
- Series B (6%)
- Series C (2%)
- Pre Seed (2%)
- Series E (1%)
- Series D (1%)
- Undisclosed (1%)
- Equity Crowdfunding (1%)
Country Focus
- United Kingdom (97%)
- United States (3%)
- France (1%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Health Diagnostics
- Analytics
- Mobile
- Medical
- Therapeutics
- Fintech
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.